AIML.CN AI/ML Innovations Inc. (CNQ) 26 Feb 2026: Trading C$0.04, model flags risk and catalysts
We see AIML.CN stock trading at C$0.04 on the CNQ Canada market during regular hours, with low liquidity and a small market cap of C$6,730,560.00. One-day price change is flat but the 50-day average is C$0.04 and the 200-day average is C$0.05, showing recent weakness. Investors focused on AI stocks should weigh the company’s digital health niche against heavy valuation and operating losses before considering exposure.
Market snapshot for AIML.CN stock and trading activity
AIML.CN stock opened at C$0.04 and traded the day between C$0.04 and C$0.04 with volume 34,376.00 and average volume 397,022.00. The share count is 168,264,000.00 and market cap is C$6,730,560.00, reflecting microcap status on CNQ in Canada. Low float and thin average volume increase volatility risk for short-term AI stock traders.
Financials and valuation metrics for AIML.CN stock
The company reports EPS -0.03 and PE -1.33, indicating persistent losses. Key ratios show price-to-sales 40.00 and price-to-book 5.23, which signal an expensive valuation relative to tiny revenue per share of 0.00. Current ratio is 2.09 and debt-to-equity is 0.11, so short-term liquidity is adequate but operating cash flow per share is negative -0.03.
Operational context and sector positioning for AIML.CN stock
AI/ML Innovations Inc. operates in digital healthcare and wearable monitoring under Medical – Healthcare Information Services. The company targets caregiver and patient health management using AI/ML, a niche within the broader Healthcare sector where peers show larger scale. Sector performance is mixed; Healthcare in Canada has underperformed Technology this year, raising comparability challenges for AI-focused healthcare microcaps.
Technical and market signals related to AIML.CN stock
Technical indicators show RSI 59.10 and ADX 14.39 indicating no clear trend. The 50-day average at C$0.04 sits below the 200-day average C$0.05, a mildly bearish medium-term signal. On-chain factors: OBV 66,597.00 suggests limited accumulation. For AI stocks, catalysts often come from partnerships or clinical validation announcements which can drive short-term spikes in microcaps.
Recent news and catalysts for AIML.CN stock
Market news listings capture basic quotes and peer comparisons; see Bloomberg and Investing.com for listings and competitor screens. Bloomberg quote on AIML:CN and Investing.com peer compare. Material catalysts would include product rollouts, pilot program wins, or updated financial reports; none were reported today, which helps explain the flat intraday price.
Meyka AI grade and analyst framing for AIML.CN stock
Meyka AI rates AIML.CN with a score out of 100: 62.32 / Grade B — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Note an external company rating dated 2026-02-24 shows C- / Strong Sell, reflecting divergence between our data-driven grade and some fundamentals-focused models. Grades are informational and not investment advice.
Final Thoughts
Key takeaways on AIML.CN stock: the share price of C$0.04 reflects microcap status, negative EPS -0.03, and thin liquidity with average volume 397,022.00. Meyka AI’s forecast model projects monthly C$0.02 (implied -50.00% vs current price) and yearly C$0.01 (C$0.00843, implied -78.84% vs current price), highlighting downside in the baseline model. For risk-tolerant AI-stock investors we outline three price targets: conservative C$0.02 (downside), base C$0.06 (moderate upside), and aggressive C$0.12 (year high tie-back). Fundamentals show high price-to-sales 40.00 and negative margins, while liquidity and potential product news remain the main catalysts. Use small position sizing, monitor corporate updates and clinical or partnership announcements, and consult the Meyka AI stock page for live updates and model changes. Forecasts are model-based projections and not guarantees.
FAQs
What is the current price of AIML.CN stock?
AIML.CN stock trades at C$0.04 on CNQ with market cap C$6,730,560.00 and volume today 34,376.00. Prices are during regular market hours and can change quickly in microcap names.
What is Meyka AI’s rating for AIML.CN stock?
Meyka AI rates AIML.CN with a score out of 100: 62.32 (Grade B) — HOLD. The grade compares S&P 500 and sector benchmarks plus financial growth and analyst consensus. This is informational, not investment advice.
What does Meyka AI’s forecast project for AIML.CN stock?
Meyka AI’s forecast model projects monthly C$0.02 (implied -50.00%) and yearly C$0.01 (C$0.00843, implied -78.84%) compared with the current C$0.04. Forecasts are model-based projections and not guarantees.
What are AIML.CN stock risks and catalysts?
Risks include operating losses, thin liquidity, high price-to-sales and low revenue per share. Catalysts are product rollouts, pilot program wins, partnerships, or clinical validation; absent new news, price movement may remain muted.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.